Compare Novavax Inc (NVAX) vs SMX Security Matters plc (SMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs SMX Security Matters plc — how do they compare? Novavax Inc trades at $7.95 (market cap $1.31B), while SMX Security Matters plc trades at $16.48 (market cap $17.04M). The key difference: Novavax Inc is far larger — about 76.9× SMX Security Matters plc's market cap, and Novavax Inc is trading nearer its 52-week high, SMX Security Matters plc nearer its low. Which is the better fit depends on your goals.
| NVAX | SMX | |
|---|---|---|
Market Cap | $1.31B | $17.04M |
Sector | Health | Technology |
52-Week High | $11.19 | $103.71K |
52-Week Low | $6.22 | $12.87 |
Enterprise Value | $889.30M | -$14.29M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NVAX trades at $7.95, up 0.76% on the day, with a bullish technical signal despite mixed indicators. The company reported a net income of $440.30M for 2025, a significant turnaround from prior losses, and has beaten earnings estimates for three consecutive quarters. Recent news highlights Q2 2026 results and a raised revenue outlook, driven by licensing milestones with Sanofi.
The outlook is cautiously optimistic given strong analyst buy ratings (73.92%) and improved financials, but risks include persistent negative cash flows, high debt, and competitive vaccine market pressures. Investment appeal hinges on execution of partnerships and cost management to sustain profitability.
SMX (Security Matters) trades at $16.16, up 2.28% on the day, but technical indicators signal a bearish trend with the stock near its pivot point. The company reported a net loss of $169.18M for 2025, with negative profitability metrics (ROE -819.22%), though recent news highlights a strengthened balance sheet and progress in commercializing its materials traceability platform amid growing regulatory demand for recycled plastics.
The outlook remains high-risk given persistent losses and cash burn, offset by potential from regulatory tailwinds in recycling. Investors face significant execution risk, but the company's niche in material verification could capture value if commercialization accelerates. The stock's viability hinges on reversing operational losses and achieving sustainable revenue growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About SMX Security Matters plc
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →
